Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Shanghai Fosun Pharmaceutical Group Co., Ltd.    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.

(600196)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
10/23/2020 10/26/2020 10/27/2020 10/28/2020 10/29/2020 Date
52.75 53.58 53.23 53.21 56.06 Last
72635340 40744550 30926880 30586390 70527930 Volume
-5.40% +1.57% -0.65% -0.04% +5.36% Change
Financials
Sales 2020 32 760 M 4 880 M 4 880 M
Net income 2020 3 552 M 529 M 529 M
Net Debt 2020 14 860 M 2 213 M 2 213 M
P/E ratio 2020 38,2x
Yield 2020 0,75%
Sales 2021 38 514 M 5 737 M 5 737 M
Net income 2021 4 166 M 621 M 621 M
Net Debt 2021 15 673 M 2 335 M 2 335 M
P/E ratio 2021 32,4x
Yield 2021 0,91%
Capitalization 107 B 15 903 M 15 939 M
EV / Sales 2020 3,72x
EV / Sales 2021 3,19x
Nbr of Employees 30 925
Free-Float 62,3%
More Financials
Company
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 5 areas of activities: - research, development and manufacturing of medicines (74.9% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases; - sale of medical equipments and diagnosis products (14.7%); - medical and... 
Sector
Pharmaceuticals
Calendar
10/30Earnings Release
More about the company
Notations Surperformance© of Shanghai Fosun Pharmaceutical Group Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.
07:00aSHANGHAI FOSUN PHARMACEUTICAL : Fochon Pharmaceuticals, Ltd. (a Subsidiary of Fo..
PU
06:10aSHANGHAI FOSUN PHARMACEUTICAL : Change of chairman and authorised representative..
PU
06:05aSHANGHAI FOSUN PHARMACEUTICAL : List of directors and their roles and function (..
PU
05:59aSHANGHAI FOSUN PHARMACEUTICAL : Nine-Month Net Profit Rose 20%
DJ
05:30aSHANGHAI FOSUN PHARMACEUTICAL : 2020 third quarterly report(h shareᦀ..
PU
10/23SHANGHAI FOSUN PHARMACEUTICAL : Connected transaction - formation of partnership..
PU
10/20SHANGHAI FOSUN PHARMACEUTICAL : Overseas regulatory announcement (h shares)
PU
10/16SHANGHAI FOSUN PHARMACEUTICAL : Date of board meeting (h shares)
PU
10/13SHANGHAI FOSUN PHARMACEUTICAL : Overseas regulatory announcement (h shares)
PU
10/09SHANGHAI FOSUN PHARMACEUTICAL : Poll results of the resolutions proposed at the ..
PU
10/09SHANGHAI FOSUN PHARMACEUTICAL : List of directors and their roles and function (..
PU
10/08Fosun unit to begin U.S. trial of COVID-19 antibody treatment soon
RE
10/08SHANGHAI FOSUN PHARMACEUTICAL : Fosun Pharma Unit Gets FDA Approval for Covid-19..
DJ
10/07SHANGHAI FOSUN PHARMACEUTICAL : Monthly return of equity issuer on movements in ..
PU
09/22SHANGHAI FOSUN PHARMACEUTICAL : Overseas regulatory announcement (h shares)
PU
More news
News in other languages on SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.
08/31Polyphor geht Lizenzvereinbarung für Balixafortide in China mit Fosun Pharma
08/21SHANGHAI FOSUN PHARMACEUTICAL GROUP : Veröffentlichung des Halbjahresergebnisse..
08/21SHANGHAI FOSUN PHARMACEUTICAL GROUP : publication des résultats semestriels
08/11Verlust von Biontech steigt - Covid-Impfstoffdaten für Oktober erwartet
08/05WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
More news
Chart SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.
Duration : Period :
Shanghai Fosun Pharmaceutical Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 38,35 CNY
Last Close Price 53,21 CNY
Spread / Highest target -1,79%
Spread / Average Target -27,9%
Spread / Lowest Target -59,7%
EPS Revisions
Managers
NameTitle
Yi Fang Wu President, CEO & Executive Director
Qi Yu Chen Co-Chairman
Fang Yao Co-Chairman
Qian Ren Chairman-Supervisory Board
Xiao Hui Guan CFO, Chief Accountant Officer & Senior VP
Sector and Competitors